O'Dorisio M S, Hermina N S, O'Dorisio T M, Balcerzak S P
J Immunol. 1981 Dec;127(6):2551-4.
Vasoactive intestinal polypeptide (VIP) was found to be a potent stimulator of lymphocyte adenylate cyclase activity. VIP-induced activation of adenylate cyclase was specific for lymphocytes among peripheral blood cells; i.e., VIP did not stimulate the adenylate cyclase activity of neutrophils, monocytes, or platelets. The VIP-induced activation of lymphocyte adenylate cyclase was time, temperature, and concentration dependent. VIP and the GTP analog, Gpp(NH)p, acted synergistically to stimulate lymphocyte adenylate cyclase; stimulation by VIP and PGE1 was additive; and VIP activation was antagonized by somatostatin. VIP-mediated activation of lymphocyte adenylate cyclase was observed in normal human T cells, B cells obtained from a patient with chronic lymphocytic leukemia, and a human T cell culture line. The Raji human B cell culture line did possess adenylate cyclase activity, but this activity was not stimulated by VIP. These results suggest that lymphocytes possess functional receptors for VIP and that this peptide may play a role in modulation of lymphocyte function.
血管活性肠肽(VIP)被发现是淋巴细胞腺苷酸环化酶活性的有效刺激剂。VIP诱导的腺苷酸环化酶激活在外周血细胞中对淋巴细胞具有特异性;也就是说,VIP不会刺激中性粒细胞、单核细胞或血小板的腺苷酸环化酶活性。VIP诱导的淋巴细胞腺苷酸环化酶激活具有时间、温度和浓度依赖性。VIP与GTP类似物Gpp(NH)p协同作用以刺激淋巴细胞腺苷酸环化酶;VIP和PGE1的刺激作用是相加的;并且VIP的激活被生长抑素拮抗。在正常人T细胞、从慢性淋巴细胞白血病患者获得的B细胞以及人T细胞培养系中均观察到VIP介导的淋巴细胞腺苷酸环化酶激活。Raji人B细胞培养系确实具有腺苷酸环化酶活性,但该活性不受VIP刺激。这些结果表明淋巴细胞具有VIP的功能性受体,并且该肽可能在淋巴细胞功能的调节中起作用。